|
 |
| 15:00-19:00 |
Registration |
| 18:00-18:15 |
Opening Keynote Address |
| |
Speech from
Sonoo H, Tsubura A, Kurebayashi J, Hilkens J, Cardiff R, Muller W |
| 18:15-18:45 |
Keynote Lecture: "Translational Research for Breast Cancer Therapy" |
| |
by Allred DC (Washington University School of Medicine, USA)
Chair:
Sonoo H (Kawasaki Medical School) |
| 19:00-21:00 |
Welcome Reception: drink and buffet at Ivy Square |
|
 |
| 8:00-9:00 |
Breakfast and Poster Session 1 |
| 9:00-11:30 |
Presidential Symposium 1: Pathology, Molecular Profiling and Genetics |
| |
| |
Chair:
Hilkens J (Netherlands Cancer Institute),
Tsubura A (Kansai Medical University) |
| (9:00-9:20) |
BRCA1and BRCA2 in breast cancer:
Ohta T (St. Marianna University School of Medicine) |
| (9:20-9:50) |
Genes and signaling pathways in breast cancer:
Hilkens J (Netherlands Cancer Institute, Netherlands) |
| |
Coffee break
|
| (10:00-10:30) |
Lobular neoplasia: Silverberg SG (University of Maryland School of Medicine, USA) |
| (10:30-11:00) |
Molecular profiling for predicting response to systemic therapies:
Paik S (NSABP, USA) |
| (11:00-11:30) |
Intrinsic subtypes of breast cancer:
Perou CM (University of North Carolina at Chapel Hill, USA) |
| |
Coffee break and pick-up of lunch box
|
| 11:50-12:50 |
Luncheon Seminar 1: Rationale for trastuzumab adjuvant therapy |
| |
| |
by Gianni L (Istituto Nazionale Tumori, Italy)
Chair:
Tokuda Y (Tokai University School of Medicine) |
| |
Coffee break
|
| 13:00-14:00 |
Plenary Lecture 1: New Targeted Therapeutics |
| |
| |
by Di Leo A (Hospital of Prato, Italy)
Chair:
Watanabe T (Hamamatsu Oncology Center Clinic) |
| 14:00-15:00 |
Selected Oral Presentation |
| |
Chair:
Saeki T (Saitama Medical University),
Ohno S (Kyushu Cancer Center) |
| |
Coffee break
|
| 15:10-16:10 |
Plenary Lecture 2: Nuclear Receptors in Breast Cancer |
| |
by Kato S (The University of Tokyo)
Chair:
Noguchi S (Osaka University Graduate School of Medicine) |
| 16:10-18:00 |
Presidential Symposium 2: Endocrine Therapy for Breast Cancer |
| |
| |
Chair:
Ito Y (Japanese Foundation for Cancer Research),
Iwase H (Kumamoto University Graduate School of Medicine) |
| (16:10-16:40) |
Estrogen receptor signaling:
Fuqua SA (Baylor College of Medicine, USA) |
| (16:40-17:10) |
Intratumoral estrogen synthesis in breast cancer and its manipulation with aromatase inhibitors: Geisler J (Oslo University, Norway) |
| |
Coffee break
|
| (17:20-17:40) |
Intracrinology:
Sasano H/Suzuki (Tohoku University) |
| (17:40-18:00) |
Resistance to endocrine therapy:
Hayashi S (Tohoku University) |
| (18:00-19:00) |
Satellite Symposium: Future Directions of Biomarkers in Breast Cancer |
| |
| |
by Allred DC (Washington University School of Medicine, USA)
Chair:
Kurebayashi J (Kawasaki Medical School)
|
| 19:30-21:30 |
Welcome Party at Tivoli Park (ticket needed) |
|
 |
| 8:00-9:00 |
Breakfast and Poster Session 2 |
| 9:00-11:30 |
Presidential Symposium 3: Chemotherapeutics |
| |
| |
Chair:
Takatsuka Y (Kansai Rosai Hospital), Ikeda T (Teikyo University School of Medicine) |
| (9:00-9:40) |
New chemotherapeutic agents in breast cancer:
Swain S (Washington Cancer Institute, USA) |
| (9:40-10:00) |
Predictive factors for response to chemotherapy:
Miyoshi Y (Hyogo Medical College) |
| |
Coffee break
|
| (10:10-10:30) |
Preoperative chemotherapy:
Nakamura S (St. Luke's International Hospital) |
| (10:30-10:50) |
Postoperative chemotherapy:
Toi M (Kyoto University Graduate School of Medicine) |
| (10:50-11:30) |
Metronomic chemotherapy:
Kerbel RS (Sunnybrook Health Sciences Centre, Canada) |
| |
Coffee break and pick-up of lunch box
|
| 11:50-12:50 |
Luncheon Seminar 2: Translational Research for Chemotherapeutics |
| |
| |
by Mackey J (University of Alberta, Canada)
Chair:
Nishimura R (Kumamoto City Hospital) |
| 12:50-14:30 |
Breast Pathology |
| |
Chair:
Moriya T(Kawasaki Medical School),
Iwata H (Aichi Cancer Center) |
| (12:50-13:10) |
Breast cancer in Thailand:
Chaiwun B (Chiang Mai University, Thailand) |
| (13:10-13:30) |
Breast cancer in China:
Gary M Tse (The Chinese University of Hong Kong, China) |
| (13:30-13:50) |
Breast cancer in Singapore:
Puay-Hoon Tan (Singapore General Hospital, Singapore) |
| (13:50-14:10) |
Breast cancer in Korea:
Eun Sook Lee (National Cancer Center, Korea) |
| (14:10-14:30) |
Evidence for a CpG Island Methylator Phenotype in Non-BRCA-Associated Early Mammary Carcinogenesis:
Seewaldt V (Duke Cancer Center, USA) |
| 14:30-15:10 |
Plenary Lecture 3: Drug resistance |
| |
by Fujita N (Japanese Foundation for Cancer Research)
Chair:
Ohuchi N (Tohoku University) |
| |
Coffee break
|
| 15:15-17:20 |
Presidential Symposium 4:
Tumor Microenvironment, Cancer Stem Cells and Signal Transduction |
| |
| |
Chair:
Hiraoka M (Kyoto University),
Inai K (Hiroshima University) |
| (15:15-15:45) |
Angiogenesis in breast cancer:
Gelmon K (British Columbia Cancer Agency, Canada) |
| (15:45-16:15) |
Cancer stem cells in breast cancer:
Cardiff R (University of California, USA) |
| |
Coffee break
|
| (16:20-16:50) |
Bone metastasis in breast cancer:
Yoneda T (Osaka University Graduate School of Dentistry) |
| (16:50-17:20) |
Signal transduction pathways in breast cancer:
Muller W (McGill University, Canada) |
| 17:20-17:30 |
Closing Ceremonies |
| |
Chair: Sonoo H (Kawasaki Medical School), Tsubura A (Kansai Medical University)
by: Desai KV (Genome Institute, Singapore) |
| 17:45-19:00 |
Tour in Ohara Museum (invited only) |
